1 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020 [J]. CA Cancer J Clin, 2020, 70(1): 7-30.
|
2 |
Kim JO, Gazala S, Razzak R, et al. Non-small cell lung cancer detection using microRNA expression profiling of bronchoalveolar lavage fluid and sputum [J]. Anticancer Res, 2015, 35(4): 1873-1880.
|
3 |
Markou A, Tsaroucha EG, Kaklamanis L, et al. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR [J]. Clin Chem, 2008, 54(10): 1696-1704.
|
4 |
Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation [J]. Eur J Cancer, 2009, 45(12): 2197-2206.
|
5 |
Su J, Anjuman N, Guarnera MA, et al. Analysis of lung flute-collected sputum for lung cancer diagnosis [J]. Biomark Insights, 2015, 10: 55-61.
|
6 |
Xing L, Su J, Guarnera MA, et al. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules [J]. Clin Cancer Res, 2015, 21(2): 484-489.
|
7 |
杨小倩, 张义宏, 孙波, 等. 痰液MicroRNAs检测在非小细胞肺癌诊断中的应用价值 [J]. 临床肺科杂志, 2013, 18(2): 226-229.
|
8 |
Yu L, Todd NW, Xing L, et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers [J]. Int J Cancer, 2010, 127(12): 2870-2878.
|
9 |
Inamura K, Ishikawa Y. MicroRNA in lung cancer: novel biomarkers and potential tools for treatment [J]. J Clin Med, 2016, 5(3): 36.
|
10 |
Bianchi F, Nicassio F, Marzi M, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer [J]. EMBO Mol Med, 2011, 3(8): 495-503.
|
11 |
Chen X, Hu Z, Wang W, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis [J]. Int J Cancer, 2012,130(7): 1620-1628.
|
12 |
Yang X, Guo Y, Du Y, et al. Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis [J]. PLoS One, 2014, 9(5):e97460.
|
13 |
Wang Y, Zhang Y, Pan C, et al. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis [J]. PLoS One, 2015, 10(2): e0118647.
|
14 |
Rokkas T, Kothonas F, Rokka A, et al. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis [J]. Eur J Gastroenterol Hepatol, 2015, 27(7): 819-825.
|
15 |
Wen SW, Zhang YF, Li Y, et al. Association of miR-21 with esophageal cancer prognosis: a meta-analysis [J]. Genet Mol Res, 2015, 14(2): 6578-6582.
|
16 |
Qu K, Lin T, Pang Q, et al. Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations [J]. Oncotarget, 2016, 7(23): 33994-34010.
|
17 |
Qu K, Zhang X, Lin T, et al. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation [J]. Sci Rep, 2017, 7(1): 1692.
|
18 |
Xing L, Su J, Guarnera MA, et al. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules [J]. Clin Cancer Res, 2015, 21(2): 484-489.
|
19 |
Razzak R, Bedard EL, Kim JO, et al. MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case-control study [J]. Curr Oncol, 2016, 23(2): e86-e94.
|